HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

12th Edition of International Conference on Neurology and Brain Disorders

October 20-22, 2025

October 20 -22, 2025 | Orlando, Florida, USA
INBC 2024

3DYNAFS-MBAFUS: A virtual lab of microbubble-amplified focused ultrasound for noninvasive treatments of neurodisorders

Speaker at Neurology Conferences - Jingsen Ma
Dynaflow, Inc, United States
Title : 3DYNAFS-MBAFUS: A virtual lab of microbubble-amplified focused ultrasound for noninvasive treatments of neurodisorders

Abstract:

Focused Ultrasound (FUS), especially when amplified by Microbubbles (MB), offers non-invasive options for treating deep-seated and brain tumors and other neurodisorders, by enabling targeted surgical ablation and/or local blood-brain-barrier opening (BBBO) for effective drug delivery. However, clinical translation faces significant challenges due to complex and intertwisted dependencies among various FUS and MB-related parameters, coupled with sensitivity to patient-specific conditions. To expedite the deployment of these non-invasive treatments using Microbubble-amplified Focused Ultrasound (MBaFUS), Dynaflow has developed a two-way coupled numerical platform, which models MBs in a Lagrangian fashion while solving acoustic and thermal fields in bio-media using an Eulerian approach. This allows for bidirectional interactions, where the acoustic field affects bubble dynamics, and bubble behavior influences pressure and heat deposition in bio-media.

MBaFUS serves as a Virtual Lab, streamlining therapy development and reducing the time and effort required for extensive testing. Researchers can explore new applications and advance basic science with this platform. Furthermore, it can function as a Treatment Planning System (TPS) in clinics for patient-specific optimizations. We demonstrate its efficacy in non-invasive deep-seated tumor ablation, validated against in vitro and ex vivo experiments where MBaFUS treatment for ex-vivo porcine tumor was conducted. Ongoing efforts to explore its potential for liquid biopsy, non-invasive diagnosis of brain diseases, will also be discussed. Lastly, we illustrate the prospects of MBaFUS's as a powerful tool to optimize Blood-Brain Barrier Opening (BBBO) for targeted drug delivery in treating neurodisorders such as Parkinson's and Alzheimer's diseases.

Biography:

Dr. Jingsen Ma is the Vice President at Dynaflow, Inc (DFI), a leading research company specializing in multiphase flow and cavitation. He earned his Ph.D. in Chemical Engineering from the Chinese Academy of Sciences in 2007, conducting postdoctoral research on air-entrained naval flows modeling at RPI until 2010. With extensive experience in computational multiphase fluid dynamics, his expertise spans various industries, including oil & gas, marine, and biomedical sectors. Dr. Ma is a renowned expert in multi-scale modeling of cavitating flows, particularly in Microbubble-amplified Focused Ultrasound (MBaFUS) applications, earning DFI prestigious awards from the American Society of Mechanical Engineers (ASME) such as the CFD Best Paper (2020), Multiphase Flow Best Paper (2021), and the Knapp Award (2022), and Innovation Award at the 2023 TechConnect World Innovation Challenge. Apart from his research, Dr. Ma is actively engaged in academic and engineering communities. He founded and leads ASME's Forum on Multiphase Flows with Bio-applications and served as the Outstanding Track Organizer of FEDSM2018. He also held positions as the Chair of the CFD Technical Committee (TC) and Vice-Chair of the Multiphase Flow TC of ASME. Currently, Dr. Ma's primary focus is seeking investment and developing joint proposals to accelerate the clinical translation and commercialization of DFI's MBaFUS—a Virtual Lab and TPS for noninvasive ablation and targeted drug delivery solutions for diseases like brain tumors, PD and AD.

Watsapp